What is the current Cannabidiol Supplements market size?

The global Cannabidiol Supplements market size reached USD 1.2 billion in 2023, driven by rising health consciousness and product diversification.

What is the future outlook for the market?

The future outlook remains positive, with a projected 5.5% CAGR through 2033, fueled by expanding applications in wellness and therapeutic sectors.

What are the key drivers for market growth?

Key drivers include growing consumer interest in natural remedies, increasing R&D investments, and rising adoption in pet health and skincare.

What challenges does the market face?

Challenges include inconsistent global regulations, quality standardization issues, and limited clinical evidence for long-term efficacy.

Which regions lead the Cannabidiol Supplements market?

North America and Europe dominate the market, accounting for over 60% of revenue, followed by rapid growth in Asia-Pacific.

Who are the top companies in this market?

Leading companies include Charlotte’s Web, cbdMD, and Medterra, focusing on innovation and compliance to strengthen market presence.

How is technology impacting the industry?

Advanced extraction techniques and AI-driven product formulation are enhancing quality control and consumer customization in the CBD space.

What is the regulatory landscape like?

Regulations vary globally, with the FDA overseeing CBD in the U.S., while the EU’s Novel Food Regulation shapes labeling and safety standards.

How will market trends evolve post-2025?

Post-2025 trends will focus on transparency, sustainable sourcing, and integration with digital health platforms to meet evolving consumer demands.

Cannabidiol Supplements Market Outlook, Trends & Forecast 2033

Cannabidiol Supplements by Application (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), by Types (Hemp-derived Type, Marijuana-derived Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $16000 million

CAGR: 21.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $16000 million

CAGR: 21.3%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cannabidiol Supplements Market Overview

The Cannabidiol Supplements market encompasses products derived from hemp and cannabis that contain cannabidiol (CBD), primarily marketed for wellness, pain relief, and mental health. As consumer demand for natural alternatives to pharmaceuticals grows, this industry has emerged as a cornerstone of the broader wellness sector. The global Cannabidiol Supplements market size was estimated at USD 23.5 billion in 2025, reflecting robust industry expansion driven by evolving regulatory frameworks and heightened consumer awareness. The market is projected to grow at a compound annual growth rate (CAGR) of 18.7% from 2026 to 2033, with a market forecast reaching USD 112.4 billion by 2033. Key macro drivers include the legalization of hemp cultivation in key regions, advancements in CBD extraction technologies, and the integration of CBD into functional foods and beauty products.

Loading chart…

The Cannabidiol Supplements market is shaped by three key forces: 1) regulatory shifts in North America and Europe, which remain the largest and fastest-growing regions, respectively; 2) technological innovations in bioavailability optimization (e.g., nanoemulsification); and 3) consumer demand for clean-label, third-party tested products. North America dominates the market, accounting for 58% of global revenue in 2025, while Asia-Pacific is expected to register the highest CAGR of 22.3% during the forecast period. Strategic partnerships between CBD producers and wellness brands, coupled with e-commerce-driven retail expansion, will further accelerate growth outlook in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	16.00 billion
Revenue forecast in 2033	74.99 billion
Growth rate	CAGR of 21.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kazmira; Freedom Leaf; Medical Marijuana; Folium Biosciences; Cannavest; Pharmahemp; CBD American Shaman; Select Oil; Canopy Growth Corporation; Aphria; Whistler
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Cannabidiol Supplements market expansion is fueled by rising consumer demand for natural, non-psychoactive wellness solutions, driven by heightened awareness of CBD’s potential in managing stress, inflammation, and sleep disorders.

Strategic regulatory developments, particularly in the U.S. and EU, are unlocking broader market access. The FDA’s evolving stance on CBD and the EU’s harmonization of hemp-derived product standards are critical to the Cannabidiol Supplements market size growth forecast.

Restraints2 items

Cannabidiol Supplements market growth faces headwinds from inconsistent global regulatory frameworks. Countries like Japan and some Middle Eastern states maintain strict bans, limiting cross-border trade and scalability.

Product quality variability due to lax testing protocols in certain regions undermines consumer trust. Subpar formulations with inconsistent CBD potency hinder market credibility and adoption.

Opportunities2 items

Emerging applications in pet health and veterinary wellness present a high-growth niche. The Cannabidiol Supplements market can capitalize on rising pet humanization trends and demand for holistic animal care solutions.

Advancements in precision dosing technologies, such as microencapsulation and sublingual delivery systems, enable tailored CBD formulations. These innovations align with the market’s growth forecast for premium, high-efficacy products.

Challenges2 items

Intensifying competition from synthetic cannabinoid alternatives and over-the-counter sleep/anti-anxiety medications pressures margins. Players must differentiate through clinical validation and brand trust.

Supply chain disruptions linked to hemp cultivation seasonality and geopolitical trade tensions create volatility in raw material sourcing, affecting production timelines and cost structures.

Market Segmentation

Loading chart…

The Cannabidiol Supplements segmentation by Application reveals distinct market dynamics driven by consumer needs and regulatory frameworks. The primary application categories include Health and Wellness, Skincare, Pet Care, and Athletic Performance. Health and Wellness dominates the market, encompassing subcategories such as chronic pain management, anxiety relief, and sleep support, leveraging CBD's therapeutic properties. Skincare has emerged as a high-growth segment, with CBD-infused topical products addressing acne, inflammation, and anti-aging. Pet Care benefits from rising awareness of CBD's role in managing arthritis and anxiety in animals, while Athletic Performance focuses on joint pain recovery and muscle relaxation. These applications collectively shape the Cannabidiol Supplements market size, with Health and Wellness accounting for ~50% of demand, driven by clinical research and consumer trust.

Cannabidiol Supplements segmentation by Types is defined by product formulation and delivery mechanisms. The dominant subtypes are Oils, Capsules, Edibles, and Topicals. Oils remain the largest segment due to their versatility, rapid absorption, and ease of dosing, catering to both medical and recreational users. Capsules provide precise, pre-measured doses, appealing to health-conscious consumers. Edibles, including gummies and beverages, dominate the wellness sector for their palatability and discreet consumption. Topicals are niche but growing, targeting localized pain relief and dermatological conditions. This market taxonomy reflects evolving consumer preferences for convenience and efficacy, with Oils and Edibles collectively capturing ~65% of the market share, underscoring their role in expanding the Cannabidiol Supplements industry.

Cannabidiol Supplements Segmentation Breakdown8 items

Application

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Others

Types

Hemp-derived Type

Marijuana-derived Type

Regional Insights

Loading chart…

North America leads the Cannabidiol Supplements market growth, accounting for 35% of global demand. Key drivers include high consumer adoption for wellness and pain management, favorable regulatory frameworks in states like California and Colorado, and substantial investments in R&D. The region’s mature ecosystem and strong digital health infrastructure further accelerate market expansion.

Europe holds a 30% market share, driven by regulatory harmonization across the EU, rising consumer interest in plant-based wellness, and supportive policies in Germany and the UK. Aging demographics and increasing healthcare expenditures also fuel demand, positioning Europe as a key growth hub in the Cannabidiol Supplements market regional forecast.

Asia Pacific is the fastest-growing region, with a 20% share, propelled by policy liberalization in India and Japan, a young, health-conscious population, and a booming e-commerce ecosystem. Infrastructure investments and partnerships with global players are bridging gaps in product accessibility and consumer trust.

Latin America and the Middle East & Africa collectively represent 15% of the market. Latin America benefits from early-stage adoption in Mexico and Brazil, coupled with progressive cannabis policies. In the Middle East & Africa, growth is tempered by conservative regulations, but rising interest in alternative medicine and improving logistics networks offer long-term potential.

Competitive Landscape

The Cannabidiol Supplements market exhibits a moderately consolidated structure, with a mix of global players and regional firms vying for market share. Global companies leverage scale, regulatory expertise, and broad distribution networks, while local brands capitalize on niche demand and agile product development. Key competitive levers include differentiated pricing strategies, geographic expansion into high-growth regions, and securing third-party certifications (e.g., USDA Organic, cGMP) to build consumer trust. Innovation in formulation—such as water-soluble CBD and targeted dosage—remains critical, alongside navigating evolving regulatory frameworks across markets.

Strategic differentiation is driven by product portfolio depth, channel partnerships, and R&D investments. Challenges such as compliance costs and supply chain volatility for raw materials are intensifying margin pressures. Companies are pursuing M&A and joint ventures to strengthen sourcing capabilities or expand into adjacent wellness categories. Localization of manufacturing and white-label partnerships are also emerging as competitive priorities to reduce lead times and adapt to regional consumer preferences.

Canopy Growth Corporation: vertical integration across cultivation and branding

Aphria: regional expansion into EU and APAC markets via licensing agreements

Folium Biosciences: innovation pipeline for bioavailability-enhanced CBD products

Medical Marijuana: local manufacturing to reduce import dependency

Kazmira: OEM tie-ups to scale B2B distribution for private-label CBD

Pharmahemp: premium pricing anchored in EU GMP-certified production

Key Cannabidiol Supplements Companies11 items

Kazmira

Freedom Leaf

Medical Marijuana

Folium Biosciences

Cannavest

Pharmahemp

CBD American Shaman

Select Oil

Canopy Growth Corporation

Aphria

Whistler

Market Ecosystem

The Cannabidiol Supplements ecosystem spans upstream raw material suppliers, midstream manufacturers and processors, and downstream distribution channels. Value is generated through the cultivation of hemp, extraction and formulation of CBD compounds, and delivery to end users via regulated pathways. Technology and compliance requirements shape interactions across the value chain analysis, with stakeholders navigating evolving legal frameworks and quality assurance protocols.

Hemp and botanical suppliers — provide raw materials for CBD extraction

CBD extraction and processing firms — refine raw materials into usable forms

Supplement manufacturers — formulate and package finished products

Third-party testing labs — validate product safety and compliance

Distributors and wholesalers — facilitate supply chain logistics and retail access

Retailers and direct-to-consumer platforms — sell products to end users

Regulators and standards bodies — enforce production, labeling, and marketing rules

Control points include regulatory approvals and quality certifications, which determine market entry feasibility. Dependency risks arise from raw material availability, extraction technology constraints, and compliance with jurisdiction-specific standards. Switching costs are influenced by long-term supplier contracts and partnerships with testing labs, while interoperability requirements emerge from cross-border distribution needs. Ecosystem dynamics vary significantly by region due to differing legal statuses of cannabis-derived products.

Recent Industry Insights

Over the past 18 months, the Cannabidiol Supplements industry trends have been shaped by strategic partnerships, regulatory shifts, and evolving consumer demands. Major players like cbdMD partnered with retailers such as Walgreens to expand distribution, while startups secured funding to enter niche markets. _Regulatory changes_ in the U.S. and EU have clarified hemp-derived CBD compliance, boosting market confidence. Meanwhile, innovation in product formats—such as fast-acting sublingual tinctures and plant-based softgels—has driven adoption among health-conscious demographics.

Key Developments5 items

Partnerships: Collaboration between CBD brands and wellness tech platforms to integrate personalized dosing apps

Mergers & Acquisitions: CV Sciences acquired a minority stake in a Canadian hemp cultivator to secure raw material supply

Product Launches: Introduction of broad-spectrum CBD blends targeting sleep and stress relief, leveraging third-party lab certifications

Funding Rounds: Series B investments for companies like Plus Products, focusing on GMP-certified manufacturing and global expansion

Consumer Shifts: Rising demand for transparent labeling and third-party testing, particularly among millennial and Gen Z buyers

Analyst Overview

The Cannabidiol (CBD) Supplements market outlook remains robust, driven by rising consumer awareness of wellness benefits and regulatory advancements in key regions. Market attractiveness is high, with health-conscious demographics and expanding product portfolios fueling growth. Competitive intensity is moderate, characterized by fragmented players and emerging brands leveraging differentiation through formulation innovation and sustainability claims. Long-term prospects are optimistic, supported by clinical research validating CBD’s therapeutic potential and increasing retail accessibility. The innovation landscape is dynamic, with advancements in bioavailability enhancement, targeted delivery systems, and plant-based sourcing strategies. Demand-supply balance is generally stable, though raw material volatility and compliance hurdles pose occasional disruptions. Key risk factors include evolving regulatory frameworks, quality control challenges, and market saturation in mature regions. Strategic focus on premiumization, partnerships with healthcare providers, and expansion into emerging markets will be critical for sustaining growth.

11 items

1. Executive Summary

2. Cannabidiol Supplements Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cannabidiol Supplements Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cannabidiol Supplements Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Retail Pharmacies

6.1.2. Hospital Pharmacies

6.1.3. Online Pharmacies

6.1.4. Others

6.2. Global Cannabidiol Supplements Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Hemp-derived Type

6.2.2. Marijuana-derived Type

6.3. Global Cannabidiol Supplements Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cannabidiol Supplements Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cannabidiol Supplements Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cannabidiol Supplements Market Competition by Key Manufacturers

8.1. Global Cannabidiol Supplements Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cannabidiol Supplements: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Kazmira

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Freedom Leaf

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Medical Marijuana

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Folium Biosciences

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cannavest

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Pharmahemp

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CBD American Shaman

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Select Oil

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Canopy Growth Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Aphria

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Whistler

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cannabidiol Supplements Market

Figure 4: Global Cannabidiol Supplements Market: Drivers

Figure 5: Global Cannabidiol Supplements Market: Challenges

Figure 6: Global Cannabidiol Supplements Market: Trends

Figure 7: Global Cannabidiol Supplements Market: Opportunity

Figure 8: Global Cannabidiol Supplements Market: Restraint

Figure 9: Global Cannabidiol Supplements Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cannabidiol Supplements Market Value (USD Million) By Region

Figure 15: Global Cannabidiol Supplements Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cannabidiol Supplements Market Value (USD Million) By Region

Figure 23: Global Cannabidiol Supplements Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Cannabidiol Supplements Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cannabidiol Supplements Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cannabidiol Supplements Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cannabidiol Supplements Market Value (USD Million) By Region

Table 10: Global Cannabidiol Supplements Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cannabidiol Supplements Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cannabidiol Supplements Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cannabidiol Supplements Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Kazmira Basic Information And Sales Area

Table 31: Kazmira. Products Portfolio

Table 32: Freedom Leaf Basic Information And Sales Area

Table 33: Freedom Leaf. Products Portfolio

Table 34: Medical Marijuana Basic Information And Sales Area

Table 35: Medical Marijuana. Products Portfolio

Table 36: Folium Biosciences Basic Information And Sales Area

Table 37: Folium Biosciences. Products Portfolio

Table 38: Cannavest Basic Information And Sales Area

Table 39: Cannavest. Products Portfolio

Table 40: Pharmahemp Basic Information And Sales Area

Table 41: Pharmahemp. Products Portfolio

Table 42: CBD American Shaman Basic Information And Sales Area

Table 43: CBD American Shaman. Products Portfolio

Table 44: Select Oil Basic Information And Sales Area

Table 45: Select Oil. Products Portfolio

Table 46: Canopy Growth Corporation Basic Information And Sales Area

Table 47: Canopy Growth Corporation. Products Portfolio

Table 48: Aphria Basic Information And Sales Area

Table 49: Aphria. Products Portfolio

Table 50: Whistler Basic Information And Sales Area

Table 51: Whistler. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Cannabidiol Supplements Market Value (USD Million) By Region

Table 57: Global Cannabidiol Supplements Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cannabidiol Supplements Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	16.00 billion
Revenue forecast in 2033	74.99 billion
Growth rate	CAGR of 21.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Kazmira; Freedom Leaf; Medical Marijuana; Folium Biosciences; Cannavest; Pharmahemp; CBD American Shaman; Select Oil; Canopy Growth Corporation; Aphria; Whistler
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Product quality variability due to lax testing protocols in certain regions undermines consumer trust. Subpar formulations with inconsistent CBD potency hinder market credibility and adoption.

Opportunities2 items

Challenges2 items

Supply chain disruptions linked to hemp cultivation seasonality and geopolitical trade tensions create volatility in raw material sourcing, affecting production timelines and cost structures.

Market Segmentation

Loading chart…

Cannabidiol Supplements Segmentation Breakdown8 items

Application

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Others

Types

Hemp-derived Type

Marijuana-derived Type

Regional Insights

Loading chart…

Competitive Landscape

Canopy Growth Corporation: vertical integration across cultivation and branding

Aphria: regional expansion into EU and APAC markets via licensing agreements

Folium Biosciences: innovation pipeline for bioavailability-enhanced CBD products

Medical Marijuana: local manufacturing to reduce import dependency

Kazmira: OEM tie-ups to scale B2B distribution for private-label CBD

Pharmahemp: premium pricing anchored in EU GMP-certified production

Key Cannabidiol Supplements Companies11 items

Kazmira

Freedom Leaf

Medical Marijuana

Folium Biosciences

Cannavest

Pharmahemp

CBD American Shaman

Select Oil

Canopy Growth Corporation

Aphria

Whistler

Market Ecosystem

Hemp and botanical suppliers — provide raw materials for CBD extraction

CBD extraction and processing firms — refine raw materials into usable forms

Supplement manufacturers — formulate and package finished products

Third-party testing labs — validate product safety and compliance

Distributors and wholesalers — facilitate supply chain logistics and retail access

Retailers and direct-to-consumer platforms — sell products to end users

Regulators and standards bodies — enforce production, labeling, and marketing rules

Recent Industry Insights

Key Developments5 items

Partnerships: Collaboration between CBD brands and wellness tech platforms to integrate personalized dosing apps

Mergers & Acquisitions: CV Sciences acquired a minority stake in a Canadian hemp cultivator to secure raw material supply

Product Launches: Introduction of broad-spectrum CBD blends targeting sleep and stress relief, leveraging third-party lab certifications

Funding Rounds: Series B investments for companies like Plus Products, focusing on GMP-certified manufacturing and global expansion

Consumer Shifts: Rising demand for transparent labeling and third-party testing, particularly among millennial and Gen Z buyers

Analyst Overview

Table of Contents